學術產出-期刊論文
文章檢視/開啟
書目匯出
-
題名 Patterns and costs of antipsychotic drug use in Taiwan: 1997 to 2001 作者 周麗芳 關鍵詞 antipsychotics;cost analysis;drug utilization;pharmacoeconomics;prescribing 日期 2003-11 上傳時間 6-一月-2009 15:22:07 (UTC+8) 摘要 The advent of atypical antipsychotics greatly changed the treatment pattern for mental illnesses worldwide. This study was designed to determine the trend in prevalence, prescribing pattern, and cost of antipsychotic agents in Taiwan from 1997 to 2001. Data were obtained from claims completed for a random sample of 200,000 people registered with the National Health Insurance program. The antipsychotics monitored included all group N05A drugs in the Anatomical Therapeutic Chemical classification system (version 2000). Conventional and atypical antipsychotics were handled separately. Of the 195,971 eligible registrants, 37,441 (19.1%) received any kind of antipsychotic during this 5-year period, but only 713 (0.4%) used atypical antipsychotics. The prevalence of conventional antipsychotic use during each successive year of this study was 5.2%, 5.7%, 6.6%, 6.2%, and 6.1% and 0.1%, 0.1%, 0.1%, 0.2%, and 0.3% for atypical agents. Although far fewer registrants used them, atypicals comprised 19.1% of all prescribed amounts measured in defined daily doses and 56.1% of the cost for all antipsychotics in 2001. During the 5-year study period, atypical antipsychotics were prescribed for 405 (57%) patients with schizophrenia, 132 (19%) with affective disorder, 128 (18%) with other psychiatric disorders, and 48 (7%) with a nonpsychiatric disorder. With the loosening of reimbursement restrictions in 2002, continued growth of atypical antipsychotic use in Taiwan might be expected. 關聯 Advances in Therapy, 20(6), 344-351 資料類型 article DOI http://dx.doi.org/10.1007/BF02849801 dc.creator (作者) 周麗芳 zh_TW dc.date (日期) 2003-11 en_US dc.date.accessioned 6-一月-2009 15:22:07 (UTC+8) - dc.date.available 6-一月-2009 15:22:07 (UTC+8) - dc.date.issued (上傳時間) 6-一月-2009 15:22:07 (UTC+8) - dc.identifier.uri (URI) https://nccur.lib.nccu.edu.tw/handle/140.119/22303 - dc.description.abstract (摘要) The advent of atypical antipsychotics greatly changed the treatment pattern for mental illnesses worldwide. This study was designed to determine the trend in prevalence, prescribing pattern, and cost of antipsychotic agents in Taiwan from 1997 to 2001. Data were obtained from claims completed for a random sample of 200,000 people registered with the National Health Insurance program. The antipsychotics monitored included all group N05A drugs in the Anatomical Therapeutic Chemical classification system (version 2000). Conventional and atypical antipsychotics were handled separately. Of the 195,971 eligible registrants, 37,441 (19.1%) received any kind of antipsychotic during this 5-year period, but only 713 (0.4%) used atypical antipsychotics. The prevalence of conventional antipsychotic use during each successive year of this study was 5.2%, 5.7%, 6.6%, 6.2%, and 6.1% and 0.1%, 0.1%, 0.1%, 0.2%, and 0.3% for atypical agents. Although far fewer registrants used them, atypicals comprised 19.1% of all prescribed amounts measured in defined daily doses and 56.1% of the cost for all antipsychotics in 2001. During the 5-year study period, atypical antipsychotics were prescribed for 405 (57%) patients with schizophrenia, 132 (19%) with affective disorder, 128 (18%) with other psychiatric disorders, and 48 (7%) with a nonpsychiatric disorder. With the loosening of reimbursement restrictions in 2002, continued growth of atypical antipsychotic use in Taiwan might be expected. - dc.format application/ en_US dc.language en en_US dc.language en-US en_US dc.language.iso en_US - dc.relation (關聯) Advances in Therapy, 20(6), 344-351 en_US dc.subject (關鍵詞) antipsychotics;cost analysis;drug utilization;pharmacoeconomics;prescribing - dc.title (題名) Patterns and costs of antipsychotic drug use in Taiwan: 1997 to 2001 en_US dc.type (資料類型) article en dc.identifier.doi (DOI) 10.1007/BF02849801 en_US dc.doi.uri (DOI) http://dx.doi.org/10.1007/BF02849801 en_US
